Table 3

Included randomised LLLT-trials.

Study by first author

Method score

Patient numbers

Application technique

Control

Trial results


Basford [53]

8

47

Tendon

Placebo

0

Gudmundsen [51]

6

92

Tendon

Placebo

++

Haker [46]

7

49

Acupoints

Placebo

0

Haker [50]

6

58

Tendon

Placebo

+

Krashenninikoff [54]

6

36

Tendon

Placebo

0

Lam [55]

7

37

Tendon

Placebo

++

L√łgdberg-Anderson [49]

7

142

Tendon

Placebo

++

Lundeberg [47]

6

57

Acupoints

Placebo

0

Oken [56]

7

59

Tendon

UL, Brace

++

Palmieri [57]

6

30

Tendon

Placebo

++

Papadoupolos [52]

4

31

Tendon

Placebo

-

Stergioulas [48]

7

62

Tendon

Placebo

++

Vasseljen [58]

8

30

Tendon

Placebo

+

Total

6.5(Mean)

730


Trial characteristics by first author, method score, laser application technique, control group type, trial results. The abbreviations used are determined by the following categories: (-) means a result in favour of the control group, (0) means a non-significant result, (+) means a positive result for LLLT in at least one outcome measure, and (++) means a consistent positive results for more than one outcome measure.

Bjordal et al. BMC Musculoskeletal Disorders 2008 9:75   doi:10.1186/1471-2474-9-75

Open Data